Literature DB >> 6399635

The use of interval estimators as a basis for decision-making in medicine.

R K Lie.   

Abstract

Mesh:

Year:  1984        PMID: 6399635     DOI: 10.1007/BF00489472

Source DB:  PubMed          Journal:  Theor Med        ISSN: 0167-9902


× No keyword cloud information.
  8 in total

1.  Effect of GL enzyme (a highly purified form of hyaluronidase) on mortality after myocardial infarction.

Authors:  E J Flint; J De Giovanni; P J Cadigan; P Lamb; B L Pentecost
Journal:  Lancet       Date:  1982-04-17       Impact factor: 79.321

2.  Cost-effectiveness of coronary artery bypass surgery.

Authors:  M C Weinstein; W B Stason
Journal:  Circulation       Date:  1982-11       Impact factor: 29.690

3.  Prospective randomized study of coronary artery bypass surgery in stable angina pectoris: a progress report on survival.

Authors: 
Journal:  Circulation       Date:  1982-06       Impact factor: 29.690

4.  Effects of early administration of a highly purified hyaluronidase preparation (GL enzyme) on myocardial infarct size.

Authors:  S Saltissi; P S Robinson; D J Coltart; M M Webb-Peploe; D N Croft
Journal:  Lancet       Date:  1982-04-17       Impact factor: 79.321

5.  Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. European Coronary Surgery Study Group.

Authors: 
Journal:  Lancet       Date:  1982-11-27       Impact factor: 79.321

6.  Intravenous hyaluronidase therapy for myocardial infarction in man: double-blind trial to assess infarct size limitation.

Authors:  J A Cairns; D A Holder; P Tanser; E Missirlis
Journal:  Circulation       Date:  1982-04       Impact factor: 29.690

7.  Fallacy of the five-year survival in lung cancer.

Authors:  B J McNeil; R Weichselbaum; S G Pauker
Journal:  N Engl J Med       Date:  1978-12-21       Impact factor: 91.245

8.  Prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Second interim report by the European Coronary Surgery Study Group.

Authors: 
Journal:  Lancet       Date:  1980-09-06       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.